Literature DB >> 21359593

Changes of organic anion transporter MRP4 and related nuclear receptors in human obstructive cholestasis.

Jin Chai1, Donglin Luo, Xiaoping Wu, Huaizhi Wang, Yu He, Qiong Li, Yanmei Zhang, Lei Chen, Zhi-Hong Peng, Tianli Xiao, Rongquan Wang, Wensheng Chen.   

Abstract

BACKGROUND: Hepatic multidrug resistance-associated protein 4 (Mrp4) levels are low, but increase markedly in rodent cholestatic liver. Nuclear receptors (NRs) are essential for regulating Mrp4 expression in cholestasis models. However, information about MRP4 and related NRs, including constitutive androstane receptor (CAR), pregnane X receptor (PXR), and retinoic X receptor-α (RXRα), is relatively lacking in human obstructive cholestasis. We collected liver samples from patients with obstructive cholestasis or without liver disease and investigated the expression of MRP4 and NRs CAR, PXR, and RXRα by semi-quantitative RT-PCR, Western blot and immunostaining assays.
RESULTS: MRP4 mRNA/protein levels were markedly increased in obstructive cholestasis. Concentration of serum total bile acids (TBA) was significantly correlated with MRP4 protein in cholestasis samples (P < 0.01). PXR and RXRα mRNA/protein levels were significantly increased in obstructive cholestasis. CAR mRNA levels were unchanged while protein levels were markedly induced in obstructive cholestasis. There was a statistically positive correlation between MRP4 mRNA and CAR protein (P < 0.05), suggesting that CAR may activate transcription of MRP4 genes by its nuclear translocation.
CONCLUSION: Hepatic MRP4 levels were dramatically induced in human obstructive cholestasis, which may reduce liver injury by increasing efflux of toxic bile acids from hepatocytes into blood.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21359593     DOI: 10.1007/s11605-011-1473-2

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  42 in total

1.  Hepatocyte-specific mutation establishes retinoid X receptor alpha as a heterodimeric integrator of multiple physiological processes in the liver.

Authors:  Y J Wan; D An; Y Cai; J J Repa; T Hung-Po Chen; M Flores; C Postic; M A Magnuson; J Chen; K R Chien; S French; D J Mangelsdorf; H M Sucov
Journal:  Mol Cell Biol       Date:  2000-06       Impact factor: 4.272

2.  Substrate specificity of human ABCC4 (MRP4)-mediated cotransport of bile acids and reduced glutathione.

Authors:  Maria Rius; Johanna Hummel-Eisenbeiss; Alan F Hofmann; Dietrich Keppler
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2005-11-10       Impact factor: 4.052

3.  The MRP4/ABCC4 gene encodes a novel apical organic anion transporter in human kidney proximal tubules: putative efflux pump for urinary cAMP and cGMP.

Authors:  Rémon A M H van Aubel; Pascal H E Smeets; Janny G P Peters; René J M Bindels; Frans G M Russel
Journal:  J Am Soc Nephrol       Date:  2002-03       Impact factor: 10.121

4.  CAR and PXR agonists stimulate hepatic bile acid and bilirubin detoxification and elimination pathways in mice.

Authors:  Martin Wagner; Emina Halilbasic; Hanns-Ulrich Marschall; Gernot Zollner; Peter Fickert; Cord Langner; Kurt Zatloukal; Helmut Denk; Michael Trauner
Journal:  Hepatology       Date:  2005-08       Impact factor: 17.425

5.  Cellular localization and up-regulation of multidrug resistance-associated protein 3 in hepatocytes and cholangiocytes during obstructive cholestasis in rat liver.

Authors:  C J Soroka; J M Lee; F Azzaroli; J L Boyer
Journal:  Hepatology       Date:  2001-04       Impact factor: 17.425

6.  Tumor necrosis factor alpha-dependent up-regulation of Lrh-1 and Mrp3(Abcc3) reduces liver injury in obstructive cholestasis.

Authors:  Alan Bohan; Wen-Sheng Chen; Lee A Denson; Matthew A Held; James L Boyer
Journal:  J Biol Chem       Date:  2003-07-01       Impact factor: 5.157

7.  Interactions between hepatic Mrp4 and Sult2a as revealed by the constitutive androstane receptor and Mrp4 knockout mice.

Authors:  Mahfoud Assem; Erin G Schuetz; Markos Leggas; Daxi Sun; Kazuto Yasuda; Glen Reid; Noam Zelcer; Masashi Adachi; Stephen Strom; Ronald M Evans; David D Moore; Piet Borst; John D Schuetz
Journal:  J Biol Chem       Date:  2004-03-05       Impact factor: 5.157

8.  Cotransport of reduced glutathione with bile salts by MRP4 (ABCC4) localized to the basolateral hepatocyte membrane.

Authors:  Maria Rius; Anne T Nies; Johanna Hummel-Eisenbeiss; Gabriele Jedlitschky; Dietrich Keppler
Journal:  Hepatology       Date:  2003-08       Impact factor: 17.425

9.  Obstructive cholestasis induces TNF-alpha- and IL-1 -mediated periportal downregulation of Bsep and zonal regulation of Ntcp, Oatp1a4, and Oatp1b2.

Authors:  Markus G Donner; Stephanie Schumacher; Ulrich Warskulat; Jane Heinemann; Dieter Häussinger
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2007-10-04       Impact factor: 4.052

10.  Characterization of the MRP4- and MRP5-mediated transport of cyclic nucleotides from intact cells.

Authors:  Peter R Wielinga; Ingrid van der Heijden; Glen Reid; Jos H Beijnen; Jan Wijnholds; Piet Borst
Journal:  J Biol Chem       Date:  2003-03-13       Impact factor: 5.157

View more
  23 in total

1.  Oral administration of oleanolic acid, isolated from Swertia mussotii Franch, attenuates liver injury, inflammation, and cholestasis in bile duct-ligated rats.

Authors:  Jin Chai; Xiaohuang Du; Sheng Chen; XinChan Feng; Ying Cheng; Liangjun Zhang; Yu Gao; Shaoxue Li; Xiaochong He; Rongquan Wang; Xiangdong Zhou; Yong Yang; Weizao Luo; Wensheng Chen
Journal:  Int J Clin Exp Med       Date:  2015-02-15

Review 2.  Drug disposition alterations in liver disease: extrahepatic effects in cholestasis and nonalcoholic steatohepatitis.

Authors:  Mark J Canet; Nathan J Cherrington
Journal:  Expert Opin Drug Metab Toxicol       Date:  2014-07-03       Impact factor: 4.481

Review 3.  An updated review on drug-induced cholestasis: mechanisms and investigation of physicochemical properties and pharmacokinetic parameters.

Authors:  Kyunghee Yang; Kathleen Köck; Alexander Sedykh; Alexander Tropsha; Kim L R Brouwer
Journal:  J Pharm Sci       Date:  2013-05-07       Impact factor: 3.534

4.  Swertianlarin, isolated from Swertia mussotii Franch, increases detoxification enzymes and efflux transporters expression in rats.

Authors:  Xin-Chan Feng; Xiaohuang Du; Sheng Chen; Dongmei Yue; Ying Cheng; Liangjun Zhang; Yu Gao; Shaoxue Li; Lei Chen; Zhihong Peng; Yong Yang; Weizao Luo; Rongquan Wang; Wensheng Chen; Jin Chai
Journal:  Int J Clin Exp Pathol       Date:  2015-01-01

5.  Elevated hepatic multidrug resistance-associated protein 3/ATP-binding cassette subfamily C 3 expression in human obstructive cholestasis is mediated through tumor necrosis factor alpha and c-Jun NH2-terminal kinase/stress-activated protein kinase-signaling pathway.

Authors:  Jin Chai; Yu He; Shi-Ying Cai; Zhongyong Jiang; Huaizhi Wang; Qiong Li; Lei Chen; Zhihong Peng; Xiaochong He; Xiaoping Wu; Tianli Xiao; Rongquan Wang; James L Boyer; Wensheng Chen
Journal:  Hepatology       Date:  2012-05       Impact factor: 17.425

6.  Hepatoprotection in bile duct ligated mice mediated by darbepoetin-α is not caused by changes in hepatobiliary transporter expression.

Authors:  Christian Eipel; Elena Menschikow; Michael Sigal; Angela Kuhla; Kerstin Abshagen; Brigitte Vollmar
Journal:  Int J Clin Exp Pathol       Date:  2012-11-20

Review 7.  Nuclear-receptor-mediated regulation of drug- and bile-acid-transporter proteins in gut and liver.

Authors:  Jeff L Staudinger; Sarah Woody; Mengxi Sun; Wenqi Cui
Journal:  Drug Metab Rev       Date:  2013-02       Impact factor: 4.518

Review 8.  Nuclear receptors in bile acid metabolism.

Authors:  Tiangang Li; John Y L Chiang
Journal:  Drug Metab Rev       Date:  2013-02       Impact factor: 4.518

9.  Mechanistic Modeling of the Hepatic Disposition of Estradiol-17β-Glucuronide in Sandwich-Cultured Human Hepatocytes.

Authors:  Katsuaki Ito; Noora Sjöstedt; Kim L R Brouwer
Journal:  Drug Metab Dispos       Date:  2019-11-19       Impact factor: 3.922

Review 10.  Bile formation and secretion.

Authors:  James L Boyer
Journal:  Compr Physiol       Date:  2013-07       Impact factor: 9.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.